Register for free to listen to this article
Listen with Speechify
0:00
2:00
CORNING, N.Y.—Corning Life Sciences, a segment of CorningInc., announced last month that it has entered into a collaboration with TAPBiosystems to provide a manufacturing automation solution for large-scale,attachment-dependent cell culture.
Under terms of the agreement, TAP will develop an automatedsystem capable of manipulating up to four Corning HYPERStack-120 Cell CultureVessels simultaneously, providing better control and more consistent results tolarge bioprocess customers who require high-throughput manufacturing.
 
 
"Biotherapeutic manufacturers are faced with developing moreproduct of better, first-time quality at less total manufactured cost," saidKen Ludwig, business manager, bioprocess and cell therapy at Corning LifeSciences. "To meet and exceed the needs of these customers, we seek ways todeliver innovative technologies to the market that improve results, increaseefficiencies and lower costs. Our collaboration with TAP is another proof pointof that commitment and to our focus on both automation and bioprocess."
 
 
This latest project follows a number of successfulcollaborations between the two companies. These include implementing Corningcryogenic vials on TAP's Fill It automated dispensing system, and HYPERFlaskcell culture vessels on TAP's CompacT SelecT automated cell culture system.
 
 
"TAP is excited to be working on another custom project withCorning Life Sciences," said Dave Thomas, product manager, Integrated CellCulture Systems, TAP Biosystems. "There is a strong need for automated tools toimprove production efficiency and we believe that the combination of Corningand TAP expertise will provide a significant step forward in this area."
 
 
The HYPERStack cell culture vessel features a unique,multi-layered design based on Corning's gas-permeable film technology anddelivers more cells in the same volumetric footprint compared to currentstacked-plate products. The increased surface area enables researchers toproduce more cells from the same cell population and reduce variability, aswell as use fewer vessels, which saves space and labor.
 
 
Corning's cell culture vessels for bioprocessing supportsuspension and attachment culture in various capacities and provide solutionsfrom cell line development, to seed train, to manufacturing.
 
 
 
Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
A 3D-rendered illustration of a eukaryotic cell highlighting organelles such as the nucleus, endoplasmic reticulum, mitochondria, and cytoskeletal structures in pink and purple tones.

Shining light on the subcellular proteome

Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue